These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 39369404

  • 1. Levamisole Induced Agranulocytosis in a Child with Steroid Dependent Nephrotic Syndrome: A Case Report.
    Anjum MF, Gupta GK, Bhandari J.
    JNMA J Nepal Med Assoc; 2024 Jul 31; 62(276):545-547. PubMed ID: 39369404
    [Abstract] [Full Text] [Related]

  • 2. Treatment effectiveness of levamisole plus prednisolone on oral lichen planus patients with emphasis on levamisole-induced agranulocytosis or pancytopenia.
    Lu SY, Chang TF, Lin CJ.
    J Formos Med Assoc; 2019 Aug 31; 118(8):1193-1201. PubMed ID: 30922614
    [Abstract] [Full Text] [Related]

  • 3. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
    Tenbrock K, Müller-Berghaus J, Fuchshuber A, Michalk D, Querfeld U.
    Pediatr Nephrol; 1998 Aug 31; 12(6):459-62. PubMed ID: 9745868
    [Abstract] [Full Text] [Related]

  • 4. Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report.
    Aoun B, Alali M, Degheili JA, Sanjad S, Vaquin C, Donadieu J, Ulinski T, Termos S.
    J Med Case Rep; 2018 Jul 16; 12(1):209. PubMed ID: 30008268
    [Abstract] [Full Text] [Related]

  • 5. Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome.
    Barbano G, Ginevri F, Ghiggeri GM, Gusmano R.
    Pediatr Nephrol; 1999 Sep 16; 13(7):602-3. PubMed ID: 10460511
    [Abstract] [Full Text] [Related]

  • 6. Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome.
    Elmas AT, Tabel Y, Elmas ON.
    Int Urol Nephrol; 2013 Aug 16; 45(4):1047-55. PubMed ID: 22826143
    [Abstract] [Full Text] [Related]

  • 7. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC, all members of the Levamisole Study Group.
    Kidney Int; 2018 Feb 16; 93(2):510-518. PubMed ID: 29054532
    [Abstract] [Full Text] [Related]

  • 8. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
    Iran J Kidney Dis; 2010 Oct 16; 4(4):292-6. PubMed ID: 20852369
    [Abstract] [Full Text] [Related]

  • 9. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
    Pediatr Nephrol; 2002 May 16; 17(5):355-8. PubMed ID: 12042893
    [Abstract] [Full Text] [Related]

  • 10. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
    Al-Saran K, Mirza K, Al-Ghanam G, Abdelkarim M.
    Pediatr Nephrol; 2006 Feb 16; 21(2):201-5. PubMed ID: 16222548
    [Abstract] [Full Text] [Related]

  • 11. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F, Ahmed TM, Samina U.
    J Coll Physicians Surg Pak; 2006 Jan 16; 16(1):35-7. PubMed ID: 16441986
    [Abstract] [Full Text] [Related]

  • 12. Recurrent Levamisole-Induced Agranulocytosis Complicated by Bowel Ischemia in a Cocaine User.
    Khan MS, Khan Z, Khateeb F, Moustafa A, Taleb M, Yoon Y.
    Am J Case Rep; 2018 Jun 01; 19():630-633. PubMed ID: 29853712
    [Abstract] [Full Text] [Related]

  • 13. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
    Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
    [Abstract] [Full Text] [Related]

  • 14. Late Onset of ANCA Vasculitis as a Side Effect of Levamisole Treatment in Nephrotic Syndrome.
    Bernardi S, Innocenti S, Charbit M, Boyer O.
    Medicina (Kaunas); 2022 May 11; 58(5):. PubMed ID: 35630067
    [Abstract] [Full Text] [Related]

  • 15. Levamisole therapy in corticosteroid-dependent nephrotic syndrome.
    Bagga A, Sharma A, Srivastava RN.
    Pediatr Nephrol; 1997 Aug 11; 11(4):415-7. PubMed ID: 9260236
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
    Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S.
    Indian Pediatr; 2014 May 11; 51(5):371-3. PubMed ID: 24953577
    [Abstract] [Full Text] [Related]

  • 17. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO, Kari JA.
    Saudi Med J; 2002 Sep 11; 23(9):1101-4. PubMed ID: 12370722
    [Abstract] [Full Text] [Related]

  • 18. Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome.
    Boyer O, Moulder JK, Grandin L, Somers MJ.
    Pediatr Nephrol; 2008 Apr 11; 23(4):575-80. PubMed ID: 18204939
    [Abstract] [Full Text] [Related]

  • 19. Liver toxicity in a nephrotic patient treated with levamisole.
    Bulugahapitiya DT.
    Arch Dis Child; 1997 Mar 11; 76(3):289. PubMed ID: 9135277
    [No Abstract] [Full Text] [Related]

  • 20. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
    Sharma S, Kalra S, Shukla S, Sharma P.
    Nephrology (Carlton); 2022 Sep 11; 27(9):758-762. PubMed ID: 35619554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.